Braeburn Pharmaceuticals
PA - Plymouth MeetingPharmaceutical
Focus: Braeburn Pharmaceuticals is a specialty pharmaceutical company focused on out-licensing and commercializing treatments in neurology, primarily opioid use disorder. The company is entirely revenue-dependent on BRIXADI (buprenorphine), a peak-stage partial opioid agonist with patent protection through 2032.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Open Jobs
5-7 this month
Cooling — net -7 jobs in 30d
2 added, 9 removed. Slower than typical.
Should You Work at Braeburn Pharmaceuticals?
AI assessmentBest fit for commercial and medical affairs professionals seeking high-impact roles in a focused specialty play with validated revenue, but unsuitable for researchers seeking deep R&D resources or career stability beyond 7 years.
Why Work Here
- Laser focus on a validated, revenue-generating asset (BRIXADI at peak lifecycle) provides commercial stability and clear go-to-market execution.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$363K Part DStable
Peak5.8yr
Sole revenue driver representing 100% of company income; partial opioid agonist with long patent runway providing commercial anchor through 2032.
Help build intelligence for Braeburn Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.